SBRT compared to sorafenib in locally advanced hepatocellular carcinoma: a propensity score analysis

被引：0

作者：

Gkika, E. ^{[1
]}

Brunner, T. ^{[2
]}

Abbasi-Senger, N. ^{[3
]}

Alheit, H.

Baus, W. ^{[4
]}

Blanck, O. ^{[5
]}

Gerum, S. ^{[6
]}

Guckenberger, M. ^{[7
]}

Habermehl, D. ^{[8
]}

Ostheimer, C. ^{[9
]}

Riesterer, O. ^{[7
]}

Tamihardja, J. ^{[10
]}

Pinato, D. J. ^{[11
]}

Rimassa, L. ^{[12
]}

Pressiani, T. ^{[12
]}

Schultheiss, M. ^{[13
]}

Sharma, R. ^{[11
]}

Burlone, M. E. ^{[14
]}

Pirisi, M. ^{[14
]}

Kudo, M. ^{[15
]}

Park, J. W. ^{[16
]}

Neumann-Haefelin, C. ^{[17
]}

Grosu, A. ^{[18
]}

Thimme, R. ^{[17
]}

Bettinger, D. ^{[17
]}

机构：

[1] Uniklin Freiburg, Radiat Oncol, Freiburg, Germany

[2] Univ Magdeburg, Radiat Oncol, Magdeburg, Germany

[3] Univ Jena, Radiat Oncol, Jena, Germany

[4] Univ Hosp Cologne, Radiat Oncol, Cologne, Germany

[5] Univ Med Ctr Schleswig Holstein, Dept Radiat Oncol, Campus Kiel, Kiel, Germany

[6] Ludwig Maximilians Univ Munchen, Dept Radiat Oncol, Munich, Germany

[7] Univ Hosp Zurich, Dept Radiat Oncol, Zurich, Switzerland

[8] Tech Univ Munich, Dept Radiat Oncol, Klinikum Rechts Isar, Munich, Germany

[9] Martin Luther Univ Halle Wittenberg, Dept Radiat Oncol, Halle, Germany

[10] Univ Hosp Wurzburg, Dept Radiat Oncol, Wurzburg, Germany

[11] Imperial Coll London, Dept Surg & Canc, Hammersmith Hosp, London, England

[12] Humanitas Canc Ctr, Humanitas Clin & Res Ctr, Med Oncol & Hematol Unit, Milan, Italy

[13] Univ Freiburg, Med Ctr, Dept Med 2, Freiburg, Germany

[14] Univ Piemonte Orientale, Dept Translat Med, Novara, Italy

[15] Kindai Univ, Sch Med, Dept Gastroenterol & Hepatol, Osakasayama, Japan

[16] Natl Canc Ctr Hosp, Ctr Liver Canc, Goyang, South Korea

[17] Univ Freiburg, Med Ctr, Dept Med 2, Freiburg, Germany

[18] Univ Freiburg, Dept Radiat Oncol, Med Ctr, Freiburg, Germany

来源：

RADIOTHERAPY AND ONCOLOGY | 2019年 / 133卷

关键词：

D O I：

10.1016/S0167-8140(19)31231-9

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

PO-0811

引用

页码：S423 / S423

页数：1

共 50 条

[41] Overall survival in response to sorafenib with transarterial chemoembolization for BCLC stage B hepatocellular carcinoma: propensity score analysis
Huang, Yonghui
Chen, Bin
Liu, Ni
Li, Nan
Dao, Haitao
Chen, Wei
Yang, Jianyong
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2017, 55 (06) : 498 - 508
[42] Concurrent Sorafenib and Radiotherapy versus Radiotherapy Alone for Locally Advanced Hepatocellular Carcinoma
Liu, C. M.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E580 - E580
[43] Hepatology: Complete regression of locally advanced hepatocellular carcinoma following Sorafenib monotherapy
Kumar, S.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2015, 30 (03) : 438 - 438
[44] Cost-Utility Analysis of Transarterial Radioembolization With Yttrium-90 Resin Microspheres Compared With Sorafenib in Locally Advanced and Inoperable Hepatocellular Carcinoma
Zarca, Kevin
Mimouni, Maroua
Pereira, Helena
Chatellier, Gilles
Vilgrain, Valerie
Durand-Zaleski, Isabelle
CLINICAL THERAPEUTICS, 2021, 43 (07) : 1201 - 1212
[45] Comparison of stereotactic body radiotherapy with and without lenvatinib for advanced hepatocellular carcinoma: a propensity score analysis
Quan Wang
Xiaoquan Ji
Jing Sun
Wengang Li
Xuezhang Duan
Aimin Zhang
Journal of Cancer Research and Clinical Oncology, 2023, 149 : 7441 - 7452
[46] Advanced hepatocellular carcinoma viral status and immunotherapy efficacy: A propensity-score matched analysis
Low, Qin Jian
Zhao, Joseph J.
Wong, Rachel Su Jen
Ho, Carol Lf
Lin, Zhaoting
Tan, Hon Lyn
Choo, Joan Re
Chan, Gloria
Ho, Jingshan
Asokumaran, Yugarajah
Sundar, Raghav
Chee, Cheng Ean
Yong, Wei Peng
ANNALS OF ONCOLOGY, 2023, 34 : S1417 - S1418
[47] Comparison of stereotactic body radiotherapy with and without lenvatinib for advanced hepatocellular carcinoma: a propensity score analysis
Wang, Quan
Ji, Xiaoquan
Sun, Jing
Li, Wengang
Duan, Xuezhang
Zhang, Aimin
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (10) : 7441 - 7452
[48] IMMUNOTHERAPY VERSUS LENVATINIB IN ADVANCED HEPATOCELLULAR CARCINOMA: A MULTICENTER, NATIONWIDE PROPENSITY SCORE MATCHING ANALYSIS
Ng, Wee Han
Yeo, Yee Hui
Singal, Amit G.
Kim, Hyunseok
Wang, Yun
Ayoub, Walid S.
Trivedi, Hirsh D.
Kuo, Alexander
Rich, Nicole E.
Parikh, Neehar D.
Guo, Zhiyong
Li, Guangming
Duan, Binwei
Ma, Kevin Sheng-Kai
Yang, Ju Dong
GASTROENTEROLOGY, 2024, 166 (05) : S1727 - S1727
[49] Sorafenib in Advanced Hepatocellular Carcinoma Reply
Llovet, Josep M.
Bruix, Jordi
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (23): : 2498 - 2499
[50] Oral sorafenib for advanced hepatocellular carcinoma
Nature Clinical Practice Oncology, 2006, 3 (12): : 648 - 649

← 1 2 3 4 5 →